🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
The purpose of this study is to generate additional safety and effectivenes...
Status
Completed
Location
Novartis Investigative Site
Start Date
2024-12-11
Trial ID
NCT05959304
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Completed
Location
Retina Associates SW
Start Date
2020-11-19
Trial ID
NCT04278417
Treatments Being Tested
This was a 64-week randomized, double-masked, multi-center, active-controll...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-09-25
Trial ID
NCT04005352
Treatments Being Tested
To evaluate the status of the blood-aqueous barrier by objectively measurin...
Status
Completed
Location
The Filatov Institute of Eye Diseases and Tissue Therapy
Start Date
2021-03-25
Trial ID
NCT07375901
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-08-23
Trial ID
NCT04058067
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-07-23
Trial ID
NCT03481634
Treatments Being Tested
Reporting early real-world clinical data of consecutive patients on the use...
Status
Unknown
Location
UZLEUVEN
Start Date
2020-12-01
Trial ID
NCT05220085
Treatments Being Tested
The purpose of this study is to assess the systemic pharmacokinetics (PK) a...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-24
Trial ID
NCT02507388
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-07-03
Trial ID
NCT03810313
Treatments Being Tested